San Francisco Marriott Marquis – Golden Gate Ballroom A/B
Supported By: An Educational Grant from AstraZeneca Pharmaceuticals

---

Program Description

Epithelial-driven inflammatory airway diseases including CRSwNP, asthma, COPD, and allergic rhinitis are characterized by their heterogeneous nature and complex pathophysiology. Traditionally, these upper and lower airway diseases have been managed independently, often leading to suboptimal patient care.

In this CME symposium, experts in pulmonology, allergy and otolaryngology will explore the complexities of epithelial-driven inflammatory airway diseases and how epithelial cytokines play a role in shaping disease severity. The expert panel will discuss the importance of managing upper and lower inflammatory airway diseases together and how the evolving treatment landscape may affect clinical practice. Clinical case scenarios will illustrate strategies for personalizing treatment plans to improve outcomes for patients with comorbid upper and lower airway diseases.

Speakers

Panelist: Flavia Hoyte, MD
National Jewish Health
Division of Allergy & Clinical Immunology
Professor
Denver, Colorado

Panelist: Ash Khanwalkar, MD
National Jewish Health
Division of Specialty Service – Otolaryngology
Assistant Professor
Denver, Colorado

Panelist: Vamsi Guntur, MD, MSc
National Jewish Health
Division of Pulmonary, Critical Care & Sleep Medicine
Professor
Denver, Colorado